Ebbert, Mark T. W.
Farrugia, Stefan L.
Sens, Jonathon P.
Jansen-West, Karen
Gendron, Tania F.
Prudencio, Mercedes
McLaughlin, Ian J.
Bowman, Brett
Seetin, Matthew
DeJesus-Hernandez, Mariely
Jackson, Jazmyne
Brown, Patricia H.
Dickson, Dennis W.
van Blitterswijk, Marka
Rademakers, Rosa
Petrucelli, Leonard
Fryer, John D.
Funding for this research was provided by:
Pharmaceutical Research and Manufacturers of America Foundation (RSGTMT17)
Florida Department of Health (8AZ10, 6AZ06)
National Institute of Neurological Disorders and Stroke (NS097261, NS099631, NS094137, NS097273, NS084974, NS099114, NS088689, NS093865)
National Institute on Aging (AG049992, AG047327)
U.S. Department of Defense (AL130125)
Amyotrophic Lateral Sclerosis Association
Robert Packard Center for ALS Research, Johns Hopkins University
Robert Packard Center for ALS Research, Johns Hopkins University
National Institute of Neurological Disorders and Stroke (NS084528)
Target ALS
Association for Frontotemporal Degeneration
Article History
Received: 5 March 2018
Accepted: 20 July 2018
First Online: 21 August 2018
Ethics approval and consent to participate
: The Mayo Clinic Institutional Review Board (IRB) approved all procedures for this study and we followed all appropriate protocols.
: All participants were properly consented for this study.
: IM, BB, and MS are full-time employees of Pacific Biosciences of California, Inc. IM’s spouse is also a full-time employee of, and owns stock in, Pacific Biosciences of California, Inc. All other authors declare they have no conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.